Danish pharmaceutical invests €2.1 billion in France
  • 5 months ago
On Thursday, Danish pharmaceutical giant Novo Nordisk announced a major investment in a French production site to expand the capacity and manufacturing of a blockbuster anti-obesity drug.
Recommended